| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1103418590 |
| P356 | DOI | 10.1186/S12885-018-4344-3 |
| P8608 | Fatcat ID | release_ncw7iblhvrafhbyzbhia3eyd3m |
| P932 | PMC publication ID | 5902941 |
| P698 | PubMed publication ID | 29665787 |
| P2093 | author name string | Liang Li | |
| Yueran Zhao | |||
| Xiaopeng Lan | |||
| Yougen Chen | |||
| Qinghua Xia | |||
| Miaoqing Zhao | |||
| Zhongxian Huang | |||
| Muyun Wei | |||
| Guoliang Lu | |||
| Shaowei Mao | |||
| P2860 | cites work | Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study. | Q51764018 |
| Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q53021222 | ||
| Epithelial-mesenchymal transition: Untangling EMT's functions. | Q53262360 | ||
| Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. | Q53410584 | ||
| Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients | Q71677727 | ||
| Alterations of Smad expression and activation in defining 2 subtypes of human head and neck squamous cell carcinoma | Q83320051 | ||
| Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma | Q89257815 | ||
| Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18 | Q24319697 | ||
| Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics | Q26849557 | ||
| Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells | Q28539104 | ||
| Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth | Q28545791 | ||
| Valproic Acid Promotes Human Glioma U87 Cells Apoptosis and Inhibits Glycogen Synthase Kinase-3β Through ERK/Akt Signaling | Q32186831 | ||
| Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients | Q33672932 | ||
| Effects of prolonged exposure to low dose metformin in thyroid cancer cell lines. | Q33702357 | ||
| The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis | Q33726074 | ||
| Metformin and cancer | Q34159241 | ||
| Epidemiology and risk factors for kidney cancer | Q34449963 | ||
| Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells. | Q34547703 | ||
| Metformin and breast and gynecological cancer risk among women with diabetes | Q35046074 | ||
| Metformin use and lung cancer risk in patients with diabetes. | Q35046673 | ||
| Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer | Q35196533 | ||
| AKT phosphorylates H3-threonine 45 to facilitate termination of gene transcription in response to DNA damage. | Q35786083 | ||
| AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab | Q35793842 | ||
| No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study. | Q35810943 | ||
| Metformin therapy and prostate cancer risk: a meta-analysis of observational studies | Q36182935 | ||
| AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition | Q36316820 | ||
| Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner | Q36320084 | ||
| Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies | Q36370966 | ||
| Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients | Q36410079 | ||
| The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma | Q37342956 | ||
| Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells | Q37579970 | ||
| Epidemiology of renal cell cancer | Q37901838 | ||
| Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts | Q38376497 | ||
| Metformin and the risk of renal cell carcinoma: a case-control analysis. | Q38409320 | ||
| Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride | Q38590960 | ||
| UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis | Q38699316 | ||
| Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer | Q38774498 | ||
| Effect of metformin on the proliferation and apoptosis of the renal cancer cell line 786-O and the underlying mechanisms | Q38822039 | ||
| Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma | Q38867200 | ||
| Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis. | Q38899340 | ||
| The relationship between platinum drug resistance and epithelial-mesenchymal transition | Q39061847 | ||
| Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells | Q39085692 | ||
| Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells | Q39159869 | ||
| Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation | Q39213121 | ||
| Progress in the application and mechanism of metformin in treating non-small cell lung cancer | Q39321321 | ||
| Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft | Q39523939 | ||
| Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma | Q39557946 | ||
| Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. | Q39630008 | ||
| Use of metformin and risk of kidney cancer in patients with type 2 diabetes | Q40249088 | ||
| No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. | Q40778391 | ||
| Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response | Q40885419 | ||
| The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling. | Q40900704 | ||
| The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts | Q41096699 | ||
| Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis | Q41303279 | ||
| Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells | Q41874831 | ||
| The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. | Q42163084 | ||
| Valproic acid resensitizes cisplatin-resistant ovarian cancer cells | Q42170797 | ||
| Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways | Q43935098 | ||
| Markers of epithelial-mesenchymal transition in renal cell carcinoma | Q44840603 | ||
| Increased activated Akt expression in renal cell carcinomas and prognosis | Q46386017 | ||
| Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer. | Q47129780 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| renal cell carcinoma | Q1164529 | ||
| P304 | page(s) | 434 | |
| P577 | publication date | 2018-04-17 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal. | |
| P478 | volume | 18 |
| Q112053038 | Advances in Renal Cell Carcinoma Drug Resistance Models |
| Q90171025 | Anticancer activity of metformin: a systematic review of the literature |
| Q98505940 | Differentiation of cancer stem cells using synthetic small molecules: toward new therapeutic strategies against therapy resistance |
| Q92612020 | Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes |
| Q93080888 | Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors |
| Q64254388 | Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling |
| Q58616531 | Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking |
| Q59138314 | Pleiotropic Effects of Metformin on Cancer |
| Q90584530 | Resveratrol inhibits ACHN cells via regulation of histone acetylation |
| Q92623870 | Single-cell RNA-seq identifies a reversible mesodermal activation in abnormally specified epithelia of p63 EEC syndrome |
| Q90704453 | Synergistic induction of apoptosis in a cell model of human leukemia K562 by nitroglycerine and valproic acid |
| Q92714278 | Targeting ROR1 inhibits epithelial to mesenchymal transition in human lung adenocarcinoma via mTOR signaling pathway |
| Q64255334 | The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets |
Search more.